Cross Cancer Institute- Alberta Health Services (AHS)

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic Solid Tumors

Studies at this site

• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations — Running, not enrolling